Header Ads

Europe's vaccine trolley crash

Europe's vaccine trolley crash

There's a classic ethical puzzle called the trolley problem: A tram is headed toward a junction. If it stays on course, it will kill five people tied to the track. By flipping a switch, a bystander can divert it to a spur line where it would claim only one victim. What to do about this dilemma?

Pragmatists might push the lever, reducing the toll, even if that turns them into active participants in another human being's death. Moralists say it's better to do nothing and remain innocent, even if that makes them observers to a larger disaster.

Europe has spent the past week  tying itself up in knots over a variation on the trolley problem. Is it acceptable to push ahead with the use of AstraZeneca's coronavirus shot despite a remote but unproven  and possibly unscientific   chance of dangerous side effects? Or is it better to avoid any possibility of causing harm, even if that turns us into passive witnesses to the Covid deaths of many others who can't get vaccinated?

A health worker prepares a dose of the AstraZeneca vaccine.

Photographer: Alessandra Tarantino/AP

The U.K. is leading the pragmatist camp, while the European Union spent the past week dithering before reluctantly pulling the switch.

The bloc's drugs regulator on Thursday cleared the AstraZeneca vaccine for a second time. The new endorsement followed the suspension of shots over concerns about a possible link to blood clots, a tiny handful of them fatal. Many European countries reversed course and authorized the shot anew, though some maintained restrictions.

Health authorities in the U.K. and the EU alike have said there's no evidence the vaccine caused the clots, and Astra says there's a higher incidence in the general public than among the millions of people who've received shots. Yet the reports of possible side effects have exposed philosophical differences over vaccination between Britain and the Continent and heightened tensions over vaccine supply shortages.

The two tracks they're on look like this: The U.K. has vaccinated around half of all adults, and its virus deaths have plunged to the lowest levels since October. The EU is lagging way behind on immunizations, and it's bracing for a third wave of contagion.—Eric Pfanner

Tracking the virus 

More Than 420 Million Shots Given

More than 400 million doses have been given across 132 countries, according to data collected by Bloomberg. In the U.S., 118 million doses have been administered. We've updated our vaccine tracker to allow you to explore vaccine rates vs Covid-19 cases in a number of countries. See the latest here.
 

Save the Date | Bloomberg New Economy Conversations with Andrew Browne: Big Pharma joined with governments to deliver vaccines in record time. The successful moonshot could spur future research into other affordable drugs. Join us March 23 at 10 a.m. EDT when Katalin Karikó, senior vice president of vaccine pioneer BioNTech, and others discuss Vaccine Miracles and the New Promise of ScienceRegister here.

What you should read

Cuomo Adopts Campaign Tactics to Cling to Job
Governor's future in doubt over pandemic, sexual harassment allegations.
How Europe Injected Doubt Into Vaccine Drive
Flip-flopping on AstraZeneca vaccine undermines public confidence. 
Religious Buildings Are Reopening in the U.S.
Reopenings in southwestern states outpacing the rest of country. 
France Sticks to GDP Target Even With Lockdown
Government still sees economy growing 6% this year even with restrictions.
Biden Calls for Covid-19 Hate Crime Law 
Americans must "change our hearts," he says after Atlanta murders.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments